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Background: Although various cross-sectional studies have shown that erythrocyte parameters, including red
blood cell (RBC), hemoglobin (Hb) and hematocrit (HCT), were linked with metabolic syndrome (MetS), few
longitudinal studies have been used to confirm their relationship. The study, therefore, constructed a large-scale
longitudinal cohort in urban Chinese population to highlight and confirm the association between erythrocyte
parameters and MetS/its components.
Methods: A longitudinal cohort with 6,453 participants was established based on the routine health check-up systems
to follow up MetS, and Generalized Estimating Equation (GEE) model was used to detect the association between
erythrocyte parameters and MetS/its components (obesity, hyperglycemia, dyslipidemia, and hypertension).
Results: 287 MetS occurred over the four-year follow-up, leading to a total incidence density of 14.19 per 1,000
person-years (287/20218 person-years). Both RBC and Hb were strongly associated with MetS (RR/95% CI, P value;
3.016/1.525-5.967, 0.002 for RBC; 3.008/1.481-6.109, 0.002 for Hb), with their dose–response trends detected. All three
erythrocyte parameters (RBC, Hb and HCT) were found to be associated with obesity, hypertension and dyslipidemia
with similar dose–response trends respectively, while only Hb showed a significant association with hyperglycemia.
Conclusions: Elevated erythrocyte parameters were confirmed to be associated with MetS/its components in urban
Chinese population, suggesting that erythrocyte parameters might be served as a potential predictor for risk of MetS.
Keywords: Metabolic syndrome (MetS), Erythrocyte parameters, Longitudinal cohort study, Generalized estimated
equation (GEE)Background
The metabolic syndrome (MetS) is characterized by obes-
ity, hyperglycemia, dyslipidemia, hypertension and insulin
resistance (IR) [1,2]. Various cross-sectional studies have
demonstrated that erythrocyte parameters, including red
blood cell (RBC), hemoglobin (Hb) and hematocrit (HCT),
were associated with MetS [2-8]. These cross-sectional
studies showed that elevated RBC was associated with
MetS in Taiwan [2], Israel [3], Korea [4], Japan [5,6], Hb
in Thailand [7] and Japan [6], HCT in Thailand [7] and* Correspondence: liu-yx@sdu.edu.cn
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reproduction in any medium, provided the orJapan [6,8]. These positive associations were further detected
in an Ethiopian cohort [9]. Furthermore, in a Japanese
cohort [10], HCT was reported to be positively associated
with insulin resistance, which is the basic pathogenesis for
MetS. As most current results were reported from cross-
sectional studies, and few from cohort studies, further
longitudinal cohort studies are required to confirm the
assumption in different populations.
The study, we established a longitudinal cohort with
6,453 participants based on the routine health check-up
systems in urban Chinese population to follow up MetS,
and each individual in this cohort was undergone at least
three repeated health checks in the five years (January
2005 to January 2010). Furthermore, Generalized Estimat-
ing Equation (GEE) model, which could handle the repeat. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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http://www.biomedcentral.com/1471-2458/13/989measurement data with high autocorrelation in the
framework of logistic regression model [11-14], was used to
detect the association between erythrocyte parameters and




A large scale longitudinal cohort was set up in 2005 on
middle-to-upper class urban Han Chinese who attended
routine health check-up at the Centers for Health Man-
agement of Shandong Provincial Hospital and Shandong
Provincial Qianfoshan Hospital. Four groups of partici-
pants without cerebral infarction, cardiovascular disease,
coronary artery bypass surgery, MetS and its single com-
ponent in their first check-up at the year of 2005, 2006,
2007 and 2008 were included in the baseline of our
longitudinal cohort study respectively. Figure 1 showed
the total of 6453 participants having at least three re-
peated health check-up within five years (January 2005
to January 2010), and the samples of repeated surveys
each year.
All individuals in the longitudinal cohort underwent a
general health questionnaire, anthropometric measure-
ments, and laboratory tests. The general health question-
naire covered the current status of smoking, alcohol
intake, diet, sleeping quality and physical activity. An-
thropometric measurements involved height, weight, and
blood pressure. Both height and weight were measured
with light clothing without shoes. Body mass index (BMI)
was calculated as weight/height2 (kg/m2) as an evidence
of obesity. Blood pressure was measured using Omron
HEM-907 by the cuff-oscillometric method on the



































Figure 1 The samples of repeated surveys at each year.mean systolic and diastolic blood pressure values of
two measurements were recorded respectively. While
the participant was fasting, a venous blood sample was
taken for laboratory test. Laboratory tests included RBC,
Hb, HCT, white blood count (WBC), platelet distribution
width (PDW), mean platelet volume (MPV), thrombocytocrit
(PCT), glucose, total cholesterol (CHOL), low-density
lipoprotein (LDL), high-density lipoprotein (HDL), triglyc-
erides (TG), gamma-glutamyl transpeptidase (GGT), serum
albumin (ALB), serum globulins (GLO), blood urea nitro-
gen (BUN), and serum creatinine (SCr), etc. This study
was approved by the Ethics Committee of School of Public
Health, Shandong University, and all participants were
given informed written consent.
Definition of the metabolic syndrome
Considering the target population was Chinese with their
specific physiological characteristics, Diabetes Branch of
the Chinese Medical Association (CDS) [15] was used
as the MetS diagnostic criteria, which is very popular
for the Chinese population in clinical practice. MetS
was defined as presence of three or more of the follow-
ing four medical conditions: 1) overweight or obesity,
i.e. BMI ≥25.0 Kg/m2; 2) hypertension, i.e. systolic
blood pressure (SBC) ≥140 mmHg, or diastolic blood
pressure (DBP) ≥90 mmHg, or previously diagnosed;
3) dyslipidemia, i.e., fasting TG ≥1.7 mmol/L, or fasting
HDL <0.9 mmol/L; 4) hyperglycemia, i.e. fasting blood-
glucose (FPG) ≥6.1 mmol/L, or 2 h Post-meal Glucose
(PG) ≥7.8 mmol/L, or previously diagnosed.
Statistical analysis
To account for missing values, multiple imputation was
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puted variables, without loss of generality, the Markov
chain Monte Carlo (MCMC) method was chosen according
to MI Procedure of SAS 9.1.3 [16]. Most variables had
less than 2% missing observations before imputation
except diet, drinking, smoking, quality of sleep and
physical activity having less than 10% missing values.
The original continuous erythrocyte parameters were
categorized into 4 levels (Q1-Q4) using the 3 quartiles
of P25, P50 and P75 as critical values, with ≤ P25 for
Q1, >P25 and ≤ P50 for Q2, >P50 and ≤ P75 for Q3,
and > P75 for Q4 respectively. Summary statistics were
used to illustrate the distribution characteristics for
variables of interest at each repeated surveys, and student's
t test for continuous variables and chi-square test for
categorical variables were used to detect the statistical
significances compared with the first survey (baseline).
As GEE model could handle the repeat measurement
data with high autocorrelation in the framework of lo-
gistic regression model [11-14], it was used to detect the
association between erythrocyte parameters and MetS/
its components. Simple GEE model was firstly used to
select variables associated with MetS/its components,
then variables which were significant at the level of
0.05 in the simple GEE analysis entered the multiple
GEE model to adjust the potential confounding. The
'Logit' link function was chosen in GEE analysis, with
significance level 0.05. All the statistical analyses were
performed on SAS 9.1.3.
Results
Table 1 summarized the characteristics of erythrocyte
parameters levels and other potential confounding fac-
tors of the participants at each repeated survey, which
showed that most factors were generally higher than that
in the first survey (baseline). A total of 294 cases of
MetS occurred over the four-year follow-up, leading to a
total incidence density of 14.19 per 1,000 person-years
(287/20218 person-years). During the follow up, 3 par-
ticipants were diagnosed as cerebral infarction (person-
years), 141 participants were diagnosed as cardiovascular
disease (person-years) and no-one underwent coronary
artery bypass surgery (see Additional file 1: Table S20).
Table 2 showed the selected variables associated with
MetS at α = 0.05 level. It indicated that each of the 3
erythrocyte parameters (RBC, Hb, and HTC) with 9 po-
tential confounding factors, including gender, age, GGT,
GLO, BUN, WBC, diet, drinking and smoking might be
linked with MetS. Also, each of the 3 erythrocyte param-
eters might be linked with the four components of MetS
with their specific potential confounding factors respect-
ively (see Additional file 2: Table S1, Additional file 3:
Table S2, Additional file 4: Table S3 and Additional
file 5: Table S4 for details).Table 3 illustrated the summarized results of the
association analyses between erythrocyte parameters
and MetS/its components after adjusting potential
confounding factors by multiple GEE model. (Confounding
variables were not shown, detailed information seeing
Additional file 6: Table S5, Additional file 7: Tables S6,
Additional file 8: Table S7, Additional file 9: Table S8,
Additional file 10: Table S9, Additional file 11: Table S10,
Additional file 12: Table S11, Additional file 13: Table S12,
Additional file 14: Table S13, Additional file 15: Table
S14, Additional file 16: Table S15, Additional file 17:
Table S16, Additional file 18: Table S17, Additional file 19:
Table S18 and Additional file 20: Table S19.). It revealed
that the top quartiles (Q4) of RBC and Hb were strongly
associated with MetS (RR/95%CI, P value; 3.016/1.525-
5.967, 0.002 for RBC; 3.008/1.481-6.109, 0.002 for Hb)
using Q1 as reference level. Although no significant for
Q2 and Q3, trends of increased of RR were observed from
Q2 to Q4, indicating that there were dose–response trends
between the 2 erythrocyte parameters and MetS. In
addition, all three erythrocyte parameters (RBC, Hb and
HCT) were found to be associated with obesity, hyper-
tension and dyslipidemia with similar dose–response
trends respectively, while only Hb showed a significant
association with hyperglycemia.
Discussions
This study mainly attempted to confirm the association
between erythrocyte parameters and MetS/its components
using the longitudinal cohort. Although the longitudinal
cohort study was based on routine health check-up in
urban Han Chinese population from middle to upper
socioeconomic strata, the positive associations between
erythrocyte parameters and MetS/its components were
observed, which were also detected in other two cohort
study [9].
RBC had been reported to be associated with MetS in
various populations by cross-sectional studies [2-6] and
in Ethiopia by a cohort studies [9]. At present study, we
not only confirmed that RBC was associated with MetS
and its 3 single components (dyslipidemia, obesity and
hypertension), but also observed the dose–response trends
(seeing Table 3 or Additional file 7: Table S6, Additional
file 8: Tables S7 and Additional file 9: Table S8). These
results highlighted the positive association between RBC
and MetS. In pathogenesis, this linkage might be
explained by the insulin resistance(IR) mechanisms in
the development of MetS, because insulin and insulin
growth factors I and II supporting erythropoiesis in
both vitro [17-21] and vivo [22-24] had been detected in
laboratory studies.
As another important erythrocyte parameter, Hb
also had been reported to be associated with MetS in
Thailand [7] and Japan [6] by Cross-sectional studies,
Table 1 Distribution of erythrocyte parameters and other potential confounding factors










age 38.563 ± 11.444 39.798 ± 11.572 40.619 ± 11.406* 42.413 ± 11.495* 43.317 ± 11.352*
sex
male 2688 2196 2415 1861 1351
female 3765 3104 3317 2681 1995
RBC 4.769 ± 0.456 4.705 ± 0.454* 4.698 ± 0.454* 4.678 ± 0.463* 4.7 ± 0.432*
Hb 142.454 ± 14.885 142.845 ± 15.27 141.73 ± 15.169* 142.569 ± 15.381 142.115 ± 16.465
HCT 42.888 ± 3.905 42.408 ± 3.951* 42.015 ± 3.889* 42.191 ± 3.964* 41.846 ± 3.869*
GGT 18.004 ± 16.393 20.016 ± 20.032* 19.383 ± 16.419* 21.08 ± 20.193* 21.336 ± 20.323*
ALB 46.575 ± 2.427 45.789 ± 2.784* 45.362 ± 2.742* 45.128 ± 2.69* 44.991 ± 2.436*
GLO 27.016 ± 3.838 27.133 ± 3.973 28.253 ± 3.972* 29.128 ± 4.046* 30.314 ± 3.826*
BUN 4.746 ± 1.197 4.698 ± 1.175* 4.664 ± 1.154* 4.772 ± 1.204 4.812 ± 1.145*
S-Cr 76.943 ± 13.736 77.897 ± 13.842* 77.502 ± 14.072* 78.587 ± 14.694* 77.012 ± 12.743
WBC 6.167 ± 1.466 6.069 ± 1.483* 6.054 ± 1.479* 6.142 ± 1.501 6.182 ± 1.489
PDW 12.346 ± 1.712 12.323 ± 1.722 12.226 ± 1.671* 12.164 ± 1.669* 12.088 ± 1.63*
MPV 10.454 ± 0.811 10.448 ± 0.946 10.42 ± 0.803* 10.398 ± 0.802* 10.428 ± 0.796
PCT 0.247 ± 0.089 0.257 ± 0.320* 0.254 ± 0.266* 0.249 ± 0.055 0.245 ± 0.054
Diet
Vegetarian 3454 2194* 2098* 1906* 1214*
normal 1863 792 750 550 463
meat-based 1118 2283 2866 2064 1653
sea food 18 31 18 22 16
Drinking
no 3698 2959 3333 2731* 1977
yes 2755 2341 2399 1811 1369
Smoking
no 5274 4323 4678 3726 2718
yes 1179 977 1054 816 628
Sleep
≥fair 6270 5173 5557 4373* 3250
<fair 183 127 175 169 96
Exercise
never/seldom 4694 3902 4267* 3469* 2477
often 1759 1398 1465 1073 869
*P < 0.05 compared with the first survey (baseline);
The abbreviations of the variables: RBC = red blood cell; Hb = Hemoglobin; HCT = Hematocrit; GGT = gamma-glutamyl transpeptidase; ALB = serum albumin;
GLO = serum globulins; BUN = blood urea nitrogen; S-Cr = serum creatinine; WBC =white blood cell; PDW= Platelet distribution width; MPV =mean platele volume;
PCT = Thrombocytocrit; Diet: 0: Vegetarian, 1: normal, 2: meat-based 3: sea food (the major kinds of food used to have); Drinking: 0: never, 1: seldom, 2: often,
wine, 3: often beer, 4: often, Chinese spirits, 5: often, mixed all kinds; Smoking: 0: never, 1: seldom, 2: quit, 3: 1-4/d, 4: 5 -15/d, 5: >15/d; Quality of sleep: 0: excellent,
1: well, 2: fair 3: poor, 4: very poor (evaluated by themselves); Physical activity 0: never, 1: seldom (1–2 times a week), 2: often or everyday (more than 3 times a week).
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association was also detected in our longitudinal cohort
study with a potential dose–response trend between them
(seeing Table 3 or Additional file 11: Table S10, Additional
file 12: Table S11, Additional file 13: Table S12, Additional
file 14: Table S13 and Additional file 15: Table S14). Thepossible mechanism might be supported by the following
pathogenesis. Hb is a well recognized carrier and buffer
of nitric oxide (NO), and various compounds of Hb with
NO can affect Hb-oxygen affinity of the whole blood
[25]. Disturbed NO synthesis may exert an adverse
effect on endothelial dysfunction through the L-arginine-
Table 2 The association analyses result from simple GEE model (MetS as dependent variable)
Quartiles Estimate ERR Z P > |Z| RR Lower 95% confidence limits Upper 95% confidence limits
red blood cell
Q4 1.284 0.244 5.271 <0.001 3.612 2.241 5.824
Q3 0.602 0.261 2.308 0.021 1.825 1.095 3.042
Q2 0.050 0.292 0.170 0.865 1.051 0.593 1.864
Q1 ref ref ref ref ref ref ref
hemoglobin
Q4 1.271 0.209 6.078 <0.001 3.564 2.366 5.370
Q3 0.492 0.232 2.118 0.034 1.635 1.037 2.577
Q2 0.251 0.240 1.045 0.296 1.285 0.803 2.056
Q1 ref ref ref ref ref ref ref
hematocrit
Q4 1.005 0.210 4.776 <0.001 2.732 1.809 4.127
Q3 0.406 0.234 1.736 0.083 1.500 0.949 2.371
Q2 0.123 0.249 0.496 0.620 1.131 0.694 1.844
Q1 ref ref ref ref ref ref ref
gender −0.946 0.157 −6.034 <0.001 0.388 0.286 0.528
age 0.410 0.039 10.596 <0.001 1.507 1.397 1.625
GGT 0.012 0.002 7.235 <0.001 1.012 1.009 1.016
ALB −0.050 0.025 −1.981 0.048 0.951 0.906 0.999
GLO 0.072 0.015 4.863 <0.001 1.074 1.044 1.106
BUN 0.177 0.049 3.599 <0.001 1.193 1.084 1.314
S-Cr 0.010 0.006 1.668 0.095 1.010 0.998 1.022
WBC 0.284 0.031 9.061 <0.001 1.328 1.249 1.412
PDW 0.005 0.042 0.119 0.905 1.005 0.926 1.091
MPV −0.093 0.094 −0.983 0.326 0.912 0.758 1.096
PCT −0.588 1.229 −0.478 0.632 0.555 0.050 6.176
Diet 0.223 0.073 3.049 0.002 1.250 1.083 1.442
Drinking 0.173 0.046 3.796 0.001 1.189 1.087 1.300
Smoking 0.143 0.044 3.246 0.001 1.153 1.058 1.257
Sleep 0.109 0.076 1.432 0.152 1.115 0.961 1.294
Exercise −0.013 0.159 −0.080 0.937 0.987 0.723 1.348
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was reported to be associated with MetS [27,28]. All these
evidences expect the association between Hb and MetS/its
components in population level.
Elevated HCT could increase blood viscosity and per-
ipheral resistance to blood flow, and further contribute
to IR [29-31]. Therefore, the association between HCT
and MetS/its components should be observed in popula-
tion level. In this paper, HCT associating with obesity,
hypertension and dyslipdemia were all detected in urban
Han Chinese population (seeing Table 3 or Additional
file 17: Table S16, Additional file 18: Table S17,
Additional file 19: Table S18), while no statisticalsignificant association between HCT and MetS/ hyper-
glycemia was found (seeing Table 3, Additional file 16:
Table S15 or Additional file 20: Table S19). Similar re-
sults were also observed in Ethiopia [9] and Japan [9] by
cohort studies, as well as in Thailand [7] and Japan
[9,11] by Cross-sectional studies.
Several limitations of this study must be considered.
a) Selection bias might exist due to the samples just
from routine health check-up population for middle-to-
upper class urban Han Chinese. b) Owing to the absence
of waist circumference measurement, the diagnostic
criteria of MetS was just based on China Diabetes
Federation, rather than international standard criteria.
Table 3 The summary results of the association analyses between erythrocyte parameters and MetS/its components after adjusting potential factors by
multiple GEE model
Parameters MetS Obesity Hyperglycemia Hypertension Dyslipdemia
Estimate P > |Z| RR Estimate P > |Z| RR Estimate P > |Z| RR Estimate P > |Z| RR Estimate P > |Z| RR
Red blood cell Q4 1.104 0.002 3.016 0.474 <0.001 1.606 0.215 0.202 1.239 0.484 0.001 1.622 0.431 <0.001 1.539
Q3 0.523 0.081 1.688 0.364 0.001 1.439 0.075 0.606 1.078 0.271 0.042 1.312 0.251 0.002 1.285
Q2 −0.039 0.895 0.961 0.006 0.955 1.006 0.068 0.605 1.071 0.113 0.389 1.120 0.123 0.103 1.131
Q1 ref ref ref ref ref ref ref ref ref ref ref ref ref ref ref
Hemolglobin Q4 1.101 0.002 3.008 0.693 <0.001 2.000 0.654 0.001 1.923 0.749 <0.001 2.114 0.536 <0.001 1.709
Q3 0.454 0.144 1.575 0.447 <0.001 1.564 0.519 0.001 1.680 0.390 0.006 1.477 0.254 0.003 1.289
Q2 0.340 0.162 1.405 0.387 <0.001 1.473 0.307 0.025 1.359 0.273 0.035 1.314 0.082 0.251 1.086
Q1 ref ref ref ref ref ref ref ref ref ref ref ref ref ref ref
Hemocrite Q4 0.583 0.079 1.792 0.362 0.009 1.436 0.028 0.874 1.029 0.368 0.021 1.445 0.257 0.009 1.293
Q3 0.214 0.479 1.238 0.297 0.013 1.346 0.151 0.320 1.163 0.324 0.018 1.383 0.195 0.018 1.215
Q2 0.034 0.892 1.035 0.220 0.028 1.246 0.014 0.915 1.014 0.149 0.250 1.161 0.003 0.969 1.003
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http://www.biomedcentral.com/1471-2458/13/989c) The medication history and menstrual history of partic-
ipants might be significant confounding factors, but they
were absent in our database. d) Hematological parameter
categories were based on a single assessment of blood,
which may cause a misclassification bias. It is, therefore,
desired to conduct a perfect longitudinal cohort study in
general population for further highlighting the association
between erythrocyte parameters and MetS.
Conclusion
In conclusion, elevated erythrocyte parameters were con-
firmed to be associated with MetS/its components in
urban Chinese population, suggesting that erythrocyte
parameters might be a potential predictor for risk of MetS.Additional files
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